XML 33 R28.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Quarterly Data (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract] |
Quarterly Data (Unaudited) | Quarterly Data (Unaudited):
|  | 2019
|  | First |  | Second |  | Third |  | Fourth |  | Total
|  | (In Millions, Except Per Share Data)
Net operating revenues |  | $ | 1,124.0 |  |  | $ | 1,135.0 |  |  | $ | 1,161.6 |  |  | $ | 1,184.4 |  |  | $ | 4,605.0 |
Operating earnings (a) |  | 167.1 |  |  | 152.6 |  |  | 151.2 |  |  | 141.2 |  |  | 612.1 |
Provision for income tax expense |  | 30.8 |  |  | 23.5 |  |  | 34.3 |  |  | 27.3 |  |  | 115.9 |
Income from continuing operations |  | 125.7 |  |  | 111.0 |  |  | 119.5 |  |  | 90.2 |  |  | 446.4 |
Loss from discontinued operations, net of tax |  | (0.5 | ) |  | (0.1 | ) |  | — |  |  | — |  |  | (0.6 | )
Net income |  | 125.2 |  |  | 110.9 |  |  | 119.5 |  |  | 90.2 |  |  | 445.8 |
Less: Net income attributable to noncontrolling interests |  | (22.9 | ) |  | (19.7 | ) |  | (21.9 | ) |  | (22.6 | ) |  | (87.1 | )
Net income attributable to Encompass Health |  | $ | 102.3 |  |  | $ | 91.2 |  |  | $ | 97.6 |  |  | $ | 67.6 |  |  | $ | 358.7 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |
Basic earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 1.05 |  |  | $ | 0.93 |  |  | $ | 0.99 |  |  | $ | 0.69 |  |  | $ | 3.66 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | — |  |  | (0.01 | )
Net income |  | $ | 1.04 |  |  | $ | 0.93 |  |  | $ | 0.99 |  |  | $ | 0.69 |  |  | $ | 3.65 |
Diluted earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 1.04 |  |  | $ | 0.92 |  |  | $ | 0.98 |  |  | $ | 0.68 |  |  | $ | 3.62 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | — |  |  | (0.01 | )
Net income |  | $ | 1.03 |  |  | $ | 0.92 |  |  | $ | 0.98 |  |  | $ | 0.68 |  |  | $ | 3.61 |
(a) | We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b) | Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.
|  | 2018
|  | First |  | Second |  | Third |  | Fourth |  | Total
|  | (In Millions, Except Per Share Data)
Net operating revenues |  | $ | 1,046.0 |  |  | $ | 1,067.7 |  |  | $ | 1,067.6 |  |  | $ | 1,096.0 |  |  | $ | 4,277.3 |
Operating earnings (a) |  | 150.0 |  |  | 157.3 |  |  | 154.5 |  |  | 93.4 |  |  | 555.2 |
Provision for income tax expense |  | 30.0 |  |  | 29.3 |  |  | 30.2 |  |  | 29.4 |  |  | 118.9 |
Income from continuing operations |  | 105.7 |  |  | 113.0 |  |  | 109.4 |  |  | 46.2 |  |  | 374.3 |
(Loss) income from discontinued operations, net of tax |  | (0.5 | ) |  | 0.2 |  |  | (0.1 | ) |  | 1.5 |  |  | 1.1 |
Net income |  | 105.2 |  |  | 113.2 |  |  | 109.3 |  |  | 47.7 |  |  | 375.4 |
Less: Net income attributable to noncontrolling interests |  | (21.4 | ) |  | (21.4 | ) |  | (20.7 | ) |  | (19.6 | ) |  | (83.1 | )
Net income attributable to Encompass Health |  | $ | 83.8 |  |  | $ | 91.8 |  |  | $ | 88.6 |  |  | $ | 28.1 |  |  | $ | 292.3 |
Earnings per common share: |  |  |  |  |  |  |  |  |  |
Basic earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.86 |  |  | $ | 0.93 |  |  | $ | 0.90 |  |  | $ | 0.27 |  |  | $ | 2.97 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | 0.02 |  |  | 0.01 |
Net income |  | $ | 0.85 |  |  | $ | 0.93 |  |  | $ | 0.90 |  |  | $ | 0.29 |  |  | $ | 2.98 |
Diluted earnings per share attributable to Encompass Health common shareholders: (b) |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.85 |  |  | $ | 0.92 |  |  | $ | 0.89 |  |  | $ | 0.26 |  |  | $ | 2.92 |
Discontinued operations |  | (0.01 | ) |  | — |  |  | — |  |  | 0.02 |  |  | 0.01 |
Net income |  | $ | 0.84 |  |  | $ | 0.92 |  |  | $ | 0.89 |  |  | $ | 0.28 |  |  | $ | 2.93 |
(a) | We define operating earnings as income from continuing operations attributable to Encompass Health before (1) loss on early extinguishment of debt; (2) interest expense and amortization of debt discounts and fees; (3) other income; and (4) income tax expense.
(b) Per share amounts may not sum due to the weighted average common shares outstanding during each quarter compared to the weighted average common shares outstanding during the entire year.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -URI http://asc.fasb.org/topic&trid=2126967 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration